CCR5 and breast carcinoma: For instance, in human breast carcinoma cells, IGF-1 can transactivate the G protein-coupled chemokine receptor CCR5 through enhancement of synthesis and secretion of RANTES mRNA, the natural ligand of CCR5 (98).